Collaboration - May 10, 2021
Glooko collaborates with Eli Lilly
Glooko has announced a strategic collaboration with Eli Lilly and Company for people with diabetes that use Lilly’s connected insulin pen solutions. The technology collaboration will ease insulin management for people with diabetes and their healthcare providers in markets outside the U.S., via integration of Lilly’s Tempo Pen and Tempo Smart Button (currently in late-stage […]
Agreement - May 5, 2021
Alligator Bioscience and BioArctic collaborate
The two companies have entered into a joint research agreement. Under the agreement, Alligator will employ its antibody generation technologies in collaboration with BioArctic to develop new product candidates, it states in a press release. “We are very pleased that BioArctic has recognized the power of Alligator’s proprietary phage display libraries which have been successfully […]
Collaboration - May 3, 2021
WASP and DDLS collaborate
The Wallenberg AI, Autonomous Systems and Software Program (WASP) and the SciLifeLab and Wallenberg National Program for Data-Driven Life Science (DDLS), will initiate a collaboration. The ultimate goal of the collaboration will be to solve ground breaking research questions and to create synergies across disciplines. The effort will bring together state-of-the-art research infrastructures, research networks […]
Collaboration - April 22, 2021
Nanoform and Aprecia enter collaboration
The two companies are exploring the synergies between their respective technologies in the field of nanoparticle-enabled 3DP dosage forms. This collaboration seeks to provide customers and the pharmaceutical industry with new capabilities in patient centric therapies, they state in a press release. The immediate product innovation target for the collaboration is to combine Nanoform’s fast […]
Clinical Trials - April 20, 2021
Novo Nordisk expands collaboration with Gilead
Gilead Sciences and Novo Nordisk have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH). The companies will conduct a phase 2b double-blind, placebo-controlled study to investigate the safety and efficacy of Novo Nordisk’s semaglutide, a GLP-1 receptor agonist, and a fixed-dose combination of Gilead’s investigational FXR agonist cilofexor and investigational ACC inhibitor firsocostat, alone and […]
Collaboration - April 19, 2021
Meet our Nordic life science stars 2021!
As an example of the versatility of the Nordic life science industry we have chosen to highlight five Nordic stars in our latest issue of the magazine. The five companies are at different stages of development, with different focus areas, from different Nordic countries, and they represent the different strongholds that the region possesses. One […]